The incorporation of strontium and zinc into a calcium-silicon ceramic for bone tissue engineering

被引:258
作者
Zreiqat, Hala [1 ]
Ramaswamy, Yogambha [1 ]
Wu, Chengtie [1 ]
Paschalidis, Angelo [1 ]
Lu, ZuFu [1 ]
James, Barbara [1 ]
Birke, Oliver [2 ]
McDonald, Michelle [2 ]
Little, David [2 ]
Dunstan, Colin R. [1 ]
机构
[1] Univ Sydney, Sch AMME, Biomat & Tissue Engn Res Unit, Sydney, NSW 2006, Australia
[2] Univ Sydney, Childrens Hosp Westmead, Sydney, NSW 2006, Australia
基金
英国医学研究理事会; 澳大利亚研究理事会;
关键词
Strontium; Zinc; CaSiO(3); Scaffolds; Bone regeneration; Orthopaedic; CELLS IN-VITRO; SIMULATED BODY-FLUIDS; BIOLOGICAL-PROPERTIES; OSTEOBLASTIC CELLS; APATITE FORMATION; CASIO3; CERAMICS; SCAFFOLDS; GLASS; VIVO; OSTEOPOROSIS;
D O I
10.1016/j.biomaterials.2010.01.024
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
In this study we developed novel scaffolds through the controlled substitution and incorporation of strontium and zinc into a calcium-silicon system to form Sr-Hardystonite (Sr-Ca(2)ZnSi(2)O(7), Sr-HT). The physical and biological properties of Sr-HT were compared to Hardystonite (Ca(2)ZnSi(2)O(7)) [HT]. We showed that Sr-HT scaffolds are porous with interconnected porous network (interconnectivity: 99%) and large pore size (300-500 mu m) and an overall porosity of 78%, combined with a relatively high compressive strength (2.16 +/- 0.52 MPa). These properties are essential for enhancing bone ingrowth in load-bearing applications. Sr-HT ceramic scaffolds induced the attachment and differentiation of human bone derived cells (HOB), compared to that for the HT scaffolds. Sr-HT scaffolds enhanced expression of alkaline phosphatase, Runx-2, osteopontin, osteocalcin and bone sialoprotein. The in vivo osteoconductivity of the scaffolds was assessed at 3 and 6 weeks following implantation in tibial bone defects in rats. Histological staining revealed rapid new growth of bone into the pores of the 3D scaffolds with the Sr-HT and HT, relative to the beta-tricalcium phosphate (beta-TCP). In vivo, HT and Sr-HT produced distinct differences in the patterns of degradation of the materials, and their association with TRAP positive osteoclast-like cells with HT appearing more resistant compared to both Sr-HT and beta-TCP. (C) 2010 Elsevier Ltd. All rights reserved.
引用
收藏
页码:3175 / 3184
页数:10
相关论文
共 35 条
[1]   Transgenic Disruption of Glucocorticoid Signaling in Mature Osteoblasts and Osteocytes Attenuates K/BxN Mouse Serum-Induced Arthritis In Vivo [J].
Buttgereit, Frank ;
Zhou, Hong ;
Kalak, Robert ;
Gaber, Timo ;
Spies, Cornelia M. ;
Huscher, Doerte ;
Straub, Ranier H. ;
Modzelewski, James ;
Dunstan, Colin R. ;
Seibel, Markus J. .
ARTHRITIS AND RHEUMATISM, 2009, 60 (07) :1998-2007
[2]   45S5 Bioglass®-derived glass-ceramic scaffolds for bone tissue engineering [J].
Chen, QZZ ;
Thompson, ID ;
Boccaccini, AR .
BIOMATERIALS, 2006, 27 (11) :2414-2425
[3]   CRYSTAL DISSOLUTION OF BIOLOGICAL AND CERAMIC APATITES [J].
DACULSI, G ;
LEGEROS, RZ ;
MITRE, D .
CALCIFIED TISSUE INTERNATIONAL, 1989, 45 (02) :95-103
[4]   In vitro bioactivity of laser ablation pseudowollastonite coating [J].
De Aza, PN ;
Fern ndez-Pradas, JM ;
Serra, P .
BIOMATERIALS, 2004, 25 (11) :1983-1990
[5]  
ElGhannam A, 1997, J BIOMED MATER RES, V36, P167, DOI 10.1002/(SICI)1097-4636(199708)36:2<167::AID-JBM5>3.0.CO
[6]  
2-I
[7]   Strontium ranelate for the treatment of osteoporosis - Is useful, but changes in bone mineral density, need careful interpretation [J].
Fogelman, I ;
Blake, GM .
BRITISH MEDICAL JOURNAL, 2005, 330 (7505) :1400-1401
[8]   The in vivo behaviour of a sol-gel glass and a glass-ceramic during critical diaphyseal bone defects healing [J].
Gil-Albarova, J ;
Salinas, AJ ;
Bueno-Lozano, AL ;
Román, J ;
Aldini-Nicolo, N ;
García-Barea, A ;
Giavaresi, G ;
Fini, M ;
Giardino, R ;
Vallet-Regí, M .
BIOMATERIALS, 2005, 26 (21) :4374-4382
[9]  
Hollinger J O, 1990, J Craniofac Surg, V1, P60, DOI 10.1097/00001665-199001000-00011
[10]   Stimulatory effect of zinc acexamate administration on fracture healing of the femoral-diaphyseal tissues in rats [J].
Igarashi, A ;
Yamaguchi, M .
GENERAL PHARMACOLOGY-THE VASCULAR SYSTEM, 1999, 32 (04) :463-469